A Randomized, Double-Blind, Dose Response Phase 2 Pilot Study of Manualized MDMA-Assisted Psychotherapy in Subjects With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2019
Price : $35 *
At a glance
- Drugs Methylenedioxymetamfetamine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 18 Sep 2013 Planned end date changed from 1 Aug 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.
- 12 Apr 2013 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 05 Apr 2013 Planned End Date changed from 1 May 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.